Journal of Pathology and Translational Medicine10.4132/jptm.2015.09.1020165011-9Molecular Dimensions of Gastric Cancer: Translational and Clinical PerspectivesYoon Young Choi, Sung Hoon Noh, Jae-Ho Cheong,,
Clinical and Translational Medicine10.1186/s40169-018-0184-7201871Merging perspectives: genotype‐directed molecular therapy for hereditary diffuse gastric cancer (HDGC) and E‐cadherin–EGFR crosstalkDandan Li, Winifred Lo, Udo Rudloff,,,,,
Cancers10.3390/cancers13205216202113205216Molecular Targets for Gastric Cancer Treatment and Future Perspectives from a Clinical and Translational Point of ViewJustus Körfer, Florian Lordick, Ulrich T. Hacker
Gastric Cancer10.5772/intechopen.697752017Clinical Implications of Molecular Heterogeneity of Gastric CancerPetra Hudler, Radovan Komel
Clinical and Translational Science10.1111/cts.12263201584320-325Clinicopathologic Implications of Eukaryotic Initiation Factor 3f and Her-2/neu Expression in Gastric CancerYu Cheng, Jin Zhou, Honglun Li
Nature Reviews Clinical Oncology10.1038/nrclinonc.2013.17020131011643-655Gastric cancer—molecular and clinical dimensionsRoopma Wadhwa, Shumei Song, Ju-Seog Lee, Yixin Yao, Qingyi Wei, Jaffer A. Ajani,,
Clinical and Translational Imaging10.1007/s40336-016-0210-y201646421-422Molecular imaging and prostate cancer: unmet clinical needs and future perspectivesStefano Fanti, Francesco Giammarile,,
Clinical and Translational Oncology10.1007/s12094-007-0041-4200794208-215Molecular biology of gastric cancerA. Cervantes, E. Rodríguez Braun, A. Pérez Fidalgo, I. Chirivella González,,
Helicobacter10.1111/j.1523-5378.2011.00880.x20111645-52Gastric Cancer: Clinical Aspects, Epidemiology and Molecular BackgroundJan Bornschein, Theodore Rokkas, Michael Selgrad, Peter Malfertheiner,
Clinical and Translational Oncology10.1007/s12094-011-0704-z2011139597-598HER2 in gastric cancer: a biomarker with clinical impact, but not without translational challengesFlorian Lordick,,